EBS - Emergent Biosolutions Non-GAAP EPS of $0.18 beats by $0.11 revenue of $307.5M beats by $24.96M
Emergent Biosolutions press release (NYSE:EBS): Q1 Non-GAAP EPS of $0.18 beats by $0.11. Revenue of $307.5M (-10.3% Y/Y) beats by $24.96M.
For further details see:
Emergent Biosolutions Non-GAAP EPS of $0.18 beats by $0.11, revenue of $307.5M beats by $24.96M